Related Experiment Video
Updated: Oct 12, 2025

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Leprosy: what is new
Avneet Randhawa1, Rajendra Kapila1, Robert A Schwartz1
1Rutgers University New Jersey Medical School, New Jersey Medical School, Newark, NJ, USA.
Leprosy (Hansen's disease) research highlights new insights into its causes, including Mycobacterium lepromatosis and zoonotic transmission. Advances include the LepVax vaccine and understanding genetic susceptibility factors.
Area of Science:
- Infectious Diseases
- Genetics
- Immunology
Background:
- Leprosy, or Hansen's disease, is a chronic granulomatous infection with significant cutaneous and neurologic manifestations.
- Historically attributed to Mycobacterium leprae, a second species, Mycobacterium lepromatosis, was identified in 2008.
- The current BCG vaccine's efficacy is variable, prompting the development of novel interventions.
Purpose of the Study:
- To provide an updated overview of leprosy research.
- To discuss emerging etiological factors, transmission routes, and genetic predispositions.
- To explore the impact of coinfections and advancements in therapeutic strategies.
Main Methods:
- Review of recent scientific literature on leprosy.
- Analysis of new findings regarding causative agents and transmission.
- Examination of genetic studies and vaccine development progress.
Main Results:
- Identification of Mycobacterium lepromatosis as an additional causative agent.
- Emerging evidence for zoonotic transmission from armadillos and Eurasian red squirrels.
- Discovery of genetic polymorphisms, like MRPS5, influencing leprosy susceptibility.
- Advancement of the LepVax subunit vaccine into human trials.
- Investigation into leprosy coinfections with COVID-19, HIV, and HTLV-1.
Conclusions:
- Leprosy research is rapidly evolving with new causative agents and transmission pathways.
- Genetic insights and novel vaccines like LepVax offer promising future directions.
- Understanding coinfections and updated treatment regimens are crucial for managing leprosy.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

